Introduction: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem involvement and a fluctuating course of disease activity (1). It affects organs such as the skin, kidneys, joints, and central nervous system, and is associated with significant morbidity and mortality (1). Patients often require long-term

Introduction: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem involvement, with mucocutaneous manifestations being among the most common and debilitating (1). Cutaneous lupus erythematosus (CLE) encompasses various subtypes including discoid lupus erythematosus (DLE), subacute CLE (SCLE), tumid lupus

Introduction Chronic spontaneous urticaria (CSU) is a skin disorder characterized by recurrent wheals, angioedema, or both for more than six weeks, in the absence of identifiable triggers (1). The disease is associated with significant impairment in quality of life due to persistent symptoms such as itching, swelling, and sleep disturbance (1). Cur

Chronic spontaneous urticaria (CSU) is marked by recurrent hives or angioedema for more than six weeks without clear triggers (1). It significantly disrupts sleep, work, and quality of life (1). Many patients remain uncontrolled on antihistamines, and alternatives are needed (1). Remibrutinib, an oral Bruton’s tyrosine kinase (BTK) inhibitor, offer

Autoimmune polyglandular syndromes are characterized by circulating autoantibodies and lymphocytic infiltration of the affected tissues or organs, eventually leading to organ failure (2). Alopecia universalis (AU) is defined as an inflammatory scarring hair loss disorder. AU is the severe form of alopecia areata characterized by the complete loss o

Introduction Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by nodules, abscesses, and sinus tracts that significantly impair quality of life and often resist therapy (1). Currently available biologics such as adalimumab benefit only a subset of patients, and therapeutic failure remains common (1). Brivekimig is

Introduction Hidradenitis Suppurativa (HS) is a chronic inflammatory skin disease characterized by painful abscesses, nodules, and draining tunnels, often leading to morbidity, scarring, and reduced quality of life (1). Treatment options remain limited, particularly in biologic-naïve moderate-to-severe disease (1). Adalimumab (anti-TNF) is approved

Artificial intelligence (AI) is reshaping healthcare operations beyond the clinical setting. This upcoming episode dives into how AI is driving smarter revenue cycle management (RCM)—from automating claims and reducing errors to improving financial outcomes for providers while keeping patient care at the center. Date: 29th September 2025 Time: 9:00

Introduction Unresectable or metastatic melanoma harboring BRAF V600 (v-Raf murine sarcoma viral oncogene homolog B) mutations represent a highly aggressive disease with historically poor prognosis. Targeted therapies against BRAF have improved outcomes, but monotherapy with BRAF inhibitors is frequently associated with the development of resistanc